Warning letter
John W Hollis Inc: warning letter of Sep 4, 2014
FDA warning letter 429765 · New Orleans District Office
Key facts
| Reference number | 429765 |
|---|---|
| Company | John W Hollis Inc |
| Subject | Unapproved New Drugs/Misbranded |
| Issue date | Sep 4, 2014 |
| Posted date | Sep 15, 2014 |
| Issuing office | New Orleans District Office |
| Product type | Drugs |
| CFR sections cited | 201.115, 210, 211, 200.10(b), 211.28(a), 211.42(c)(10)(iii), 211.42(c)(10)(iv), 211.42(c)(10)(v), 211.113(b), 211.166(a), 211.167(a), 210.1(b) |
| Inspection city | Nashville |
| Inspection ZIP | 37203 |
| Inspection start date | Feb 4, 2014 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: